Scott D Bringans (Scott Bringans)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Palliative Care

Mass Spectrometry

Top Venues

Journal of clinical medicine

Clinical proteomics

This page only lists publications with an associated author ORCID identifier.

Publications

Kirsten E Peters, Scott D Bringans, Ronan S O'Neill, Tasha S C Lumbantobing, James K C Lui, Timothy M E Davis, Michael K Hansen, Richard J Lipscombe
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores. Journal of clinical medicine 12 (9) (2023)
Kirsten E Peters, Scott D Bringans, Ronan S O'Neill, Tasha S C Lumbantobing, James K C Lui, Timothy M E Davis, Michael K Hansen, Richard J Lipscombe
Canagliflozin Attenuates PromarkerD Diabetic Kidney Disease Risk Prediction Scores. Journal of clinical medicine 12 (9) (2023)
Scott D Bringans, Kirsten E Peters, Tammy Casey, Jason Ito, Richard Lipscombe
The New and the Old: Platform Cross-Validation of Immunoaffinity MASS Spectrometry versus ELISA for PromarkerD, a Predictive Test for Diabetic Kidney Disease. Proteomes 8 (4) (2020)
Scott D Bringans, Jason Ito, Tammy Casey, Sarah Thomas, Kirsten Peters, Ben Crossett, Orla Coleman, Holger A Ebhardt, Stephen R Pennington, Richard Lipscombe
A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease. Clinical proteomics 17 (2020)